TDP-43 pathologic lesions and clinical phenotype in frontotemporal lobar degeneration with ubiquitin-positive inclusions

Archives of Neurology

Volumn 64, Issue 10, 2007, Pages 1449-1454

  Grossman, Murray ^a   Wood, Elisabeth M ^a   Moore, Peachie ^a   Neumann, Manuela ^a,b   Kwong, Linda ^a   Forman, Mark S ^a   Clark, Christopher M ^a   McCluskey, Leo F ^a   Miller, Bruce L ^c   Lee, Virginia M Y ^a   Trojanowski, John Q ^a  

^a UNIVERSITY OF PENNSYLVANIA   (United States)

^b UNIVERSITY OF MUNICH   (Germany)

^c UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

DNA BINDING PROTEIN; PROTEIN TDP 43; UBIQUITIN; UNCLASSIFIED DRUG;

ARTICLE; BRAIN DEGENERATION; CLINICAL ARTICLE; CLINICAL FEATURE; CONTROLLED STUDY; DEGENERATIVE DISEASE; FRONTOTEMPORAL DEMENTIA; FRONTOTEMPORAL LOBAR DEGENERATION; HISTOPATHOLOGY; HUMAN; MOTOR NEURON DISEASE; NERVE DEGENERATION; PHENOTYPE; PRIORITY JOURNAL; PROTEIN EXPRESSION;

AGED; AUTOPSY; BRAIN; COGNITION; DATA INTERPRETATION, STATISTICAL; DEMENTIA; DNA-BINDING PROTEINS; FEMALE; HUMANS; IMMUNOHISTOCHEMISTRY; INCLUSION BODIES; MALE; MIDDLE AGED; NEUROPSYCHOLOGICAL TESTS; PHENOTYPE; PSYCHOMOTOR PERFORMANCE; RETROSPECTIVE STUDIES; UBIQUITIN;

EID: 35348862535     PISSN: 00039942     EISSN: 15383687     Source Type: Journal    
DOI: 10.1001/archneur.64.10.1449     Document Type: Article

References (40)

1. Grossman M. Frontotemporal dementia: a review. J Int Neuropsychol Soc. 2002;8(4):566-583.
2. Snowden JS, Neary D, Mann DM. Fronto-temporal Lobar Degeneration: Frontotemporal Dementia, Progressive Aphasia, Semantic Dementia. New York, NY: Churchill Livingstone; 1996.
3. Knopman DS, Petersen RC, Edland SD, Cha RH, Rocca WA. The incidence of frontotemporal lobar degeneration in Rochester, Minnesota, 1990 through 1994. Neurology. 2004;62(3):506-508.
4. Ratnavalli E, Brayne C, Dawson K, Hodges JR. The prevalence of frontotemporal dementia. Neurology. 2002;58(11):1615-1621.
5. Rosso SM, Kaat LD, Baks T, et al. Frontotemporal dementia in the Netherlands: patient characteristics and prevalence estimates from a population-based study. Brain. 2003;126(pt 9):2016-2022.
6. Forman MS, Farmer J, Johnson JK, et al. Frontotemporal dementia: clinicopathological correlations. Ann Neurol. 2006;59(6):952-962.
7. Hodges JR, Davies RR, Xuereb J, et al. Clinicopathological correlates in frontotemporal dementia. Ann Neurol. 2004;56(3):399-406.
8. Lipton AM, White CL, Bigio EH. Frontotemporal lobar degeneration with motor neuron disease-type inclusions predominates in 76 cases of frontotemporal degeneration. Acta Neuropathol (Berl). 2004;108(5):379-385.
9. Lomen-Hoerth C, Anderson T, Miller BL. The overlap of amyotrophic lateral sclerosis and frontotemporal dementia. Neurology. 2002;59(7):1077-1079.
10. Lomen-Hoerth C, Murphy J, Langmore S, Kramer JH, Olney RK, Miller B. Are amyotrophic lateral sclerosis patients cognitively normal? Neurology. 2003;60(7):1094-1097.
11. Davidson Y, Kelley T, Mackenzie IR, et al. Ubiquitinated pathological lesions in frontotemporal lobar degeneration contain the TAR DNA-binding protein, TDP-43. Acta Neuropathol (Berl). 2007;113(5):521-533.
12. Neumann M, Sampathu DM, Kwong LK, et al. Ubiquinated TDP-43 in frontotemporal lobar degeneration and amyotrophic lateral sclerosis. Science. 2006;314(5796):130-133.
13. Mackenzie IR, Baborie A, Pickering-Brown S, et al. Heterogeneity of ubiquitin pathology in frontotemporal lobar degeneration: classification and relation to clinical phenotype. Acta Neuropathol (Berl). 2006;112(5):539-549.
14. Sampathu DM, Neumann M, Kwong LK, et al. Pathological heterogeneity of frontotemporal lobar degeneration with ubiquitin-positive inclusions delineated by ubiquitin immunohistochemistry and novel monoclonal antibodies. Am J Pathol. 2006;169(4):1343-1352.
15. Kertesz A, McMonagle P, Blair M, Davidson W, Munoz DG. The evolution and pathology of frontotemporal dementia. Brain. 2005;128(pt 9):1996-2005.
16. Lund and Manchester Groups. Clinical and neuropathological criteria for frontotemporal dementia. J Neurol Neurosurg Psychiatry. 1994;57(4):416-418.
17. McKhann GM, Trojanowski JQ, Grossman M, Miller BL, Dickson D, Albert M. Clinical and pathological diagnosis of frontotemporal dementia: report of a work group on frontotemporal dementia and Pick's disease. Arch Neurol. 2001;58(11):1803-1809.
18. Grossman M, Ash S. Primary progressive aphasia: a review. Neurocase. 2004;10(1):3-18.
19. Neary D, Snowden JS, Gustafson L, et al. Frontotemporal lobar degeneration: a consensus on clinical diagnostic criteria. Neurology. 1998;51(6):1546-1554.
20. National Institute on Aging and Reagan Institute Working Group on Diagnostic Criteria for the Neuropathological Assessment of Alzheimer's Disease. Consensus recommendations for the postmortem diagnosis of Alzheimer's disease. Neurobiol Aging. 1997;18(4)(suppl):S1-S2.
21. Dickson DW, Bergeron C, Chin SS, et al. Office of Rare Diseases neuropathologic criteria for corticobasal degeneration. J Neuropathol Exp Neurol. 2002;61(11):935-946.
22. Gilman S, Low PA, Quinn N, et al. Consensus statement on the diagnosis of multiple system atrophy. J Neurol Sci. 1999;163(1):94-98.
23. Hauw JJ, Daniel SE, Dickson D, Horoupian D, Jellinger K, Lantos P. Preliminary NINDS neuropathologic criteria for Steele-Richardson-Olszewski syndrome (progressive supranuclear palsy). Neurology. 1994;44(11):2015-2019.
24. McKeith IG, Fairbairn AF, Bothwell RA, et al. An evaluation of the predictive validity and inter-rater reliability of clinical diagnostic criteria for senile dementia of the Lewy body type. Neurology. 1994;44(5):872-877.
25. Forman MS, Mackenzie IR, Cairns NJ, et al. Novel ubiquitin neuropathology in frontotemporal dementia with valosin-containing protein gene mutations. J Neuropathol Exp Neurol. 2006;65(6):571-581.
26. Cairns NJ, Neumann M, Mackenzie IR, et al. Neuropathologic heterogeneity in familial and sporadic TDP-43 proteinopathy. Am J Pathol. In press.
27. Fleischman DA, Wilson RS, Gabrieli JDE, Schneider JA, Bienias JL, Bennett DA. Implicit memory and Alzheimer's disease neuropathology. Brain. 2005;128(pt 9):2006-2015.
28. Grossman M, Libon DJ, Forman MS, et al. Distinct antemortem profiles in pathologically defined patients with frontotemporal dementia. Arch Neurol. In press.
29. Harasty JA, Halliday GM, Xuereb J, Croot K, Bennett H, Hodges JR. Cortical degeneration associated with phonologic and semantic language impairments in AD. Neurology. 2001;56(7):944-950.
30. Lipton AM, Cullum CM, Satumtira S, et al. Contribution of asymmetric synapse loss to lateralizing clinical deficits in frontotemporal dementias. Arch Neurol. 2001;58(8):1233-1239.
31. Van Deerlin VMD, Wood EM, Moore P, et al. Clinical, genetic, and pathological characteristics of patients with frontotemporal dementia and progranulin mutations. Arch Neurol. 2007;64(8):1148-1153.
32. Gass J, Cannon A, Mackenzie IR, et al. Mutations in progranulin are a major cause of ubiquitin-positive frontotemporal lobar degeneration. Hum Mol Genet. 2006;15(20):2988-3001.
33. Mesulam M, Johnson N, Krefft TA, et al. Progranulin mutations in primary progressive aphasia: the PPA1 and PPA3 families. Arch Neurol. 2007;64(1):43-47.
34. Hodges JR, Davies R, Xuereb J, Kril JJ, Halliday GM. Survival in frontotemporal dementia. Neurology. 2003;61(3):349-354.
35. Roberson ED, Hesse JH, Rose KD, et al. Frontotemporal dementia progresses to death faster than Alzheimer disease. Neurology. 2005;65(5):719-725.
36. del Aguila MA, Longstreth WT, McGuire V, Koepsell TD, van Belle G. Prognosis in amyotrophic lateral sclerosis: a population-based study. Neurology. 2003;60(5):813-819.
37. Sorenson EJ, Stalker AP, Kurland LT, Windebank AJ. Amyotrophic lateral sclerosis in Olmsted County, Minnesota, 1925 to 1998. Neurology. 2002;59(2):280-282.
38. Josephs KA, Knopman DS, Whitwell JL, et al. Survival in two variants of taunegative frontotemporal lobar degeneration: FTLD-U vs FTLD-MND. Neurology. 2005;65(4):645-647.
39. Rascovsky K, Salmon DP, Lipton AM, et al. Rate of progression differs in frontotemporal dementia and Alzheimer disease. Neurology. 2005;65(3):397-403.
40. Xie SX, Forman MS, Farmer J, et al. Factors associated with survival probability in autopsy-proven frontotemporal dementia. J Neurol Neurosurg Psychiatry. In press.